|
|
Volumn 11, Issue 1, 2004, Pages 13-17
|
|
Cancer, apoptosis, and nonimmune surveillance
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOPTOTIC PROTEASE ACTIVATING FACTOR 1;
CANCER TESTIS ANTIGEN;
CELL DNA;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FAS ANTIGEN;
FAS LIGAND;
HYBRID PROTEIN;
IMATINIB;
INTEGRIN RECEPTOR;
METHOTREXATE;
MUTANT PROTEIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN KINASE B;
PROTEIN P53;
RETINOBLASTOMA PROTEIN;
SURVIVIN;
TRASTUZUMAB;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER;
CANCER CELL;
DNA DAMAGE;
DNA REPAIR;
EPIGENETICS;
GENE AMPLIFICATION;
GENE FUSION;
GENE OVEREXPRESSION;
GROWTH DISORDER;
HUMAN;
INTERCELLULAR SPACE;
INTRACELLULAR SPACE;
ONCOGENE;
PRIORITY JOURNAL;
PROTEIN FAMILY;
PROTEIN TARGETING;
APOPTOSIS;
DNA DAMAGE;
DNA REPAIR;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MUTATION;
NEOPLASMS;
TUMOR ESCAPE;
|
|
EID: 1642433140
PISSN: 13509047
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.cdd.4401342 Document Type: Article |
|
Times cited : (56)
|
|
References (14)
|
